Breaking News Instant updates and real-time market news.

UA

Under Armour

$16.79

-0.365 (-2.13%)

, UAA

Under Armour

$18.20

-0.42 (-2.26%)

12:43
10/20/18
10/20
12:43
10/20/18
12:43

Under Armour stock could triple, Barron's says

Under Armour has had a bumpy ride the last couple of years, but has recovered some of the losses amid significant management changes, Al Root writes in this week's edition of Barron's. It could be a good time to take a fresh look at the stock as a contrarian bet, before margins improve and Wall Street warms to the turnaround plan, Root says. Reference Link

UA

Under Armour

$16.79

-0.365 (-2.13%)

UAA

Under Armour

$18.20

-0.42 (-2.26%)

  • 30

    Oct

  • 30

    Oct

  • 27

    Nov

  • 03

    Mar

UA Under Armour
$16.79

-0.365 (-2.13%)

08/29/18
BARD
08/29/18
NO CHANGE
Target $27
BARD
Outperform
Under Armour selloff on Dick's 'head fake' a buying opportunity, says Baird
Baird analyst Jonathan Komp noted that while Dick's Sporting Goods (DKS) reported its own "disappointing" earnings, the company called out continued sales challenges for Under Armour (UAA), which it attributed to expanded distribution. He believes current sporting goods disruption for Under Armour is already reflected in the company's 2018 earnings guidance and also believes other mid-tier channels have continued to show strong sales performance, pointing out that Kohl's (KSS) saw Under Armour accelerate in Q2. Komp, who views the selloff on Dick's comments a "compelling buying opportunity," keeps an Outperform rating and $27 price target on Under Armour Class A shares.
09/21/18
JPMS
09/21/18
UPGRADE
Target $20
JPMS
Neutral
Under Armour upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Matthew Boss upgraded Under Armour to Neutral and raised his price target for the shares to $20 from $16. The analyst views the stock's risk/reward as more balanced following the recent underperformance. Further, Under Armour's multi-year margin initiative announced yesterday "protect this house," Boss tells investors in a research note.
09/21/18
09/21/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) upgraded to Neutral from Underweight at JPMorgan with analyst Matthew Boss saying he views the stock's risk/reward as more balanced following the recent underperformance. 2. Acadia (ACAD) upgraded to Overweight from Neutral at Piper Jaffray with analyst Danielle Brill citing the FDA announcement of maintained support for Nuplazid after its review. 3. AT&T (T) upgraded to Buy from Neutral at UBS with analyst John Hodulik saying the stock is trading near all-time low valuations, and at its widest valuation gap to Verizon (VZ), given a mix of EBITDA declines, concerns over the debt load and secular issues impacting the space. 4. Diamond Offshore (DO) upgraded to Buy from Hold at HSBC. 5. Ingersoll-Rand (IR) upgraded to Overweight from Neutral at JPMorgan with analyst Stephen Tusa saying he views the stock's discounted valuation relative to peers as unwarranted following the company's transformation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/27/18
JEFF
09/27/18
NO CHANGE
JEFF
Under Armour promos down for six straight month, says Jefferies
Jefferies analyst Randal Konik says his firm's September webscrapes illustrate that Under Armour's (UAA) percentage of product on discount is down for the sixth month in a row, while Adidas's (ADDYY) is up seven months in a row. Visits to Finish Line (FINL), Foot Locker (FL), and Under Armour websites reveal the HOVR and Curry 5 are sold out in several sizes and colors, indicating growing brand awareness, Konik tells investors in a research note. He believes Under Armour's promos being down bode well for the company's Q3 results. Further, Nike (NKE) continues to regain share from Adidas in running across the U.S., with strength in Air VaporMax, Air Max 270, and Roshe One, the analyst adds.
UAA Under Armour
$18.20

-0.42 (-2.26%)

09/21/18
JEFF
09/21/18
NO CHANGE
Target $29
JEFF
Buy
Under Armour restructuring news 'should squash' margin doubt, says Jefferies
After the company announced an update to its restructuring plan, Jefferies analyst Randal Konik says he's impressed with Under Armour's "ability to parallel-track operational excellence alongside leading product innovation." Recent successes with the HOVR platform and Project Rock "have quieted bears" who doubted product and brand strength, and yesterday's news "should squash any doubt surrounding the positive trajectory for sustainable operating margin improvement ahead," Konik tells investors in a research note. He reiterates a Buy rating on Under Armour with a $29 price target.

TODAY'S FREE FLY STORIES

EPAY

Bottomline Technologies

$49.99

-0.31 (-0.62%)

07:21
12/11/18
12/11
07:21
12/11/18
07:21
Conference/Events
Bottomline Technologies management to meet with Needham »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

07:20
12/11/18
12/11
07:20
12/11/18
07:20
General news
FX Update: The dollar traded moderately softer »

FX Update: The dollar…

T

AT&T

$29.91

-0.23 (-0.76%)

07:19
12/11/18
12/11
07:19
12/11/18
07:19
Upgrade
AT&T rating change  »

Citi upgrades AT&T to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 20

    Mar

ENTX

Entera Bio

$5.20

0.25 (5.05%)

, AMGN

Amgen

$194.16

2.73 (1.43%)

07:17
12/11/18
12/11
07:17
12/11/18
07:17
Hot Stocks
Entera Bio, Amgen enter license agreement for inflammatory and other diseases »

Entera Bio (ENTX)…

ENTX

Entera Bio

$5.20

0.25 (5.05%)

AMGN

Amgen

$194.16

2.73 (1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

VRAY

ViewRay

$6.59

0.3 (4.77%)

07:16
12/11/18
12/11
07:16
12/11/18
07:16
Initiation
ViewRay initiated  »

Morgan Stanley sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$39.60

-1.03 (-2.54%)

07:16
12/11/18
12/11
07:16
12/11/18
07:16
Recommendations
MetLife analyst commentary  »

Citi keeps Sell rating on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

EFX

Equifax

$98.46

-1.11 (-1.11%)

07:15
12/11/18
12/11
07:15
12/11/18
07:15
Conference/Events
Equifax management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

ITCI

Intra-Cellular

$15.34

0.23 (1.52%)

07:13
12/11/18
12/11
07:13
12/11/18
07:13
Hot Stocks
Intra-Cellular announces FDA accepts lumateperone NDA for review »

Intra-Cellular announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPZ

Domino's Pizza

$255.25

-3.32 (-1.28%)

07:13
12/11/18
12/11
07:13
12/11/18
07:13
Conference/Events
Domino's Pizza management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 14

    Dec

DSW

DSW

$23.04

-1.19 (-4.91%)

07:12
12/11/18
12/11
07:12
12/11/18
07:12
Hot Stocks
Breaking Hot Stocks news story on DSW »

DSW up 16.7% to $27.00…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

TSN

Tyson Foods

$55.42

-0.78 (-1.39%)

07:12
12/11/18
12/11
07:12
12/11/18
07:12
Initiation
Tyson Foods initiated  »

Tyson Foods reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

DSW

DSW

$23.04

-1.19 (-4.91%)

07:11
12/11/18
12/11
07:11
12/11/18
07:11
Hot Stocks
DSW says ends Q3 with inventories of $624M »

The company ended the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NMIH

NMI Holdings

$18.14

-0.17 (-0.93%)

07:10
12/11/18
12/11
07:10
12/11/18
07:10
Initiation
NMI Holdings initiated  »

NMI Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$23.04

-1.19 (-4.91%)

07:09
12/11/18
12/11
07:09
12/11/18
07:09
Earnings
Breaking Earnings news story on DSW »

DSW: Camuto Group to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

GNL

Global Net Lease

07:09
12/11/18
12/11
07:09
12/11/18
07:09
Initiation
Global Net Lease initiated  »

Global Net Lease…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRBK

Green Brick

$8.01

0.02 (0.25%)

07:09
12/11/18
12/11
07:09
12/11/18
07:09
Initiation
Green Brick initiated  »

Green Brick initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPTN

Optinose

$8.01

-0.07 (-0.87%)

07:08
12/11/18
12/11
07:08
12/11/18
07:08
Hot Stocks
Optinose, Avanir Pharmaceuticals to terminate Onzetra Xsail license agreement »

Optinose announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

STML

Stemline

$10.36

0.38 (3.81%)

07:07
12/11/18
12/11
07:07
12/11/18
07:07
Initiation
Stemline initiated  »

Stemline initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DSW

DSW

$23.04

-1.19 (-4.91%)

07:07
12/11/18
12/11
07:07
12/11/18
07:07
Earnings
DSW sees Q4 EPS excluding Camuto Group 1c-11c, consensus 19c »

Sees Q4 EPS including…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

WPP

WPP

$51.13

-0.98 (-1.88%)

07:06
12/11/18
12/11
07:06
12/11/18
07:06
Earnings
WPP expects to report FY18 results in line with consensus estimates »

WPP provided the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

FBK

FB Financial

$35.66

-0.17 (-0.47%)

07:06
12/11/18
12/11
07:06
12/11/18
07:06
Initiation
FB Financial initiated  »

FB Financial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENB

Enbridge

$31.40

-0.54 (-1.69%)

, SEP

Spectra Energy Partners

$34.83

-0.6 (-1.69%)

07:05
12/11/18
12/11
07:05
12/11/18
07:05
Hot Stocks
Enbridge making progress on buy-in of interest in Sponsored Vehicles »

Enbridge (ENB) continues…

ENB

Enbridge

$31.40

-0.54 (-1.69%)

SEP

Spectra Energy Partners

$34.83

-0.6 (-1.69%)

EEP

Enbridge Energy

$10.47

-0.18 (-1.69%)

EEQ

Enbridge Energy Management

$10.48

-0.16 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

SPN

Superior Energy

$4.14

-0.15 (-3.50%)

07:05
12/11/18
12/11
07:05
12/11/18
07:05
Downgrade
Superior Energy rating change  »

Superior Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNX

Athenex

$12.46

0.35 (2.89%)

07:05
12/11/18
12/11
07:05
12/11/18
07:05
Hot Stocks
Athenex announces results from second cohort of Oraxol plus ramucirumab trial »

Athenex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENB

Enbridge

$31.40

-0.54 (-1.69%)

07:05
12/11/18
12/11
07:05
12/11/18
07:05
Hot Stocks
Enbridge announces $1.8B of new accretive growth capital investments »

Enbridge is announcing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.